Accrued Liabilities, Current in USD of Achilles Therapeutics plc from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Achilles Therapeutics plc quarterly Accrued Liabilities, Current history and change rate from Q4 2020 to Q2 2024.
  • Achilles Therapeutics plc Accrued Liabilities, Current for the quarter ending 30 Jun 2024 was $7.23M, a 4.55% decline year-over-year.
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Change (%)

Achilles Therapeutics plc Quarterly Accrued Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $7.23M -$344K -4.55% 30 Jun 2024 6-K 14 Aug 2024
Q4 2023 $7.83M -$464K -5.6% 31 Dec 2023 6-K 14 Aug 2024
Q2 2023 $7.57M 30 Jun 2023 6-K 04 Aug 2023
Q4 2022 $8.29M -$2.61M -24% 31 Dec 2022 20-F 04 Apr 2024
Q4 2021 $10.9M +$4.32M +65.5% 31 Dec 2021 20-F 07 Mar 2023
Q4 2020 $6.59M 31 Dec 2020 20-F 01 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.